EP Patent

EP1385509A1 — Method of treatment

Assigned to SmithKline Beecham Corp · Expires 2004-02-04 · 22y expired

What this patent protects

The invention relates to a method of maintaining glycemic control in diabetic hypertensive patients which comprises administering carvedilol to a subject in need thereof.

USPTO Abstract

The invention relates to a method of maintaining glycemic control in diabetic hypertensive patients which comprises administering carvedilol to a subject in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number: EP1385509A1
Jurisdiction: EP
Classification: —
Expires: 2004-02-04
Drug substance claim: No
Drug product claim: No
Assignee: SmithKline Beecham Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.